BEDMINSTER, N.J. and DUBLIN, Ireland, May 29, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that John F. Thero, Amarin's President, is scheduled to present a general corporate update at the Jefferies 2012 Global Healthcare Conference to be held at the Grand Hyatt New York. The presentation will take place on June 7, 2012 at 12:30 p.m. EDT. A live webcast of the presentation will be available at the following URL:
